New eye drops for nearsightedness pass early safety check
NCT ID NCT05470881
First seen Feb 05, 2026 · Last updated May 21, 2026 · Updated 15 times
Summary
This early-stage study tested whether PRO-201 eye drops (a low-dose atropine solution) are safe for the eyes. It involved 29 healthy adults aged 18 to 35. Researchers monitored side effects, light sensitivity, vision, eye pressure, and comfort after applying the drops. The goal was to gather safety data before testing in people with myopia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IIMET Investigación e Innovación en Medicina Traslacional
Guadalajara, Jalisco, 44610, Mexico
Conditions
Explore the condition pages connected to this study.